|
|
|
Chapter 1 Caffeine and Nutrition: an Overview |
|
|
3 | (19) |
|
Rubem Carlos Araujo Guedes |
|
|
Marlison Jose Lima de Aguiar |
|
|
Cilene Rejane Ramos Alves-de-Aguiar |
|
|
1.1 Introduction: Caffeine Consumption and its Effects on the Organism |
|
|
3 | (3) |
|
1.2 Pharmacodynamics and Pharmacokinetics of Caffeine |
|
|
6 | (1) |
|
1.3 Caffeine-Nutrition Interaction: Effects on Physiological Processes |
|
|
7 | (1) |
|
1.4 Caffeine-Nutrition Interaction: Latent Inhibition Model of Attention |
|
|
8 | (3) |
|
1.5 Caffeine-Nutrition Interaction on Cortical Spreading Depression |
|
|
11 | (2) |
|
|
13 | (9) |
|
|
14 | (1) |
|
Key Facts of Latent Inhibition (LI) |
|
|
15 | (1) |
|
Key Facts of Cortical Spreading Depression (CSD) |
|
|
16 | (1) |
|
Definitions and Explanations of Key Terms |
|
|
16 | (2) |
|
|
18 | (1) |
|
|
18 | (1) |
|
|
18 | (4) |
|
Chapter 2 Caffeine as an Ingredient in Sugar Sweetened Beverages |
|
|
22 | (19) |
|
|
|
|
|
2.1 Introduction: Caffeine Consumption Patterns |
|
|
22 | (1) |
|
|
23 | (3) |
|
2.2.1 Withdrawal from Caffeine |
|
|
24 | (1) |
|
2.2.2 Is Caffeine a Drug of Dependence? |
|
|
25 | (1) |
|
2.3 Caffeine as a Flavor Agent |
|
|
26 | (2) |
|
|
28 | (1) |
|
2.5 Caffeine in Sugar Sweetened Beverages |
|
|
29 | (1) |
|
|
29 | (1) |
|
|
30 | (1) |
|
2.7.1 Cross Sectional Studies |
|
|
30 | (1) |
|
2.7.2 Prospective Studies and Weight Change |
|
|
30 | (1) |
|
2.7.3 Intervention Trials of SSB and Body Weight |
|
|
31 | (1) |
|
2.7.4 Studies Finding no Association between SSB and Weight Change |
|
|
31 | (1) |
|
2.8 Linking Caffeine in SSB and Development of Overweight and Obesity |
|
|
31 | (1) |
|
2.9 Would Decreasing Caffeine in SSB Impact Body Weight? |
|
|
32 | (1) |
|
|
33 | (8) |
|
|
34 | (1) |
|
|
34 | (1) |
|
|
35 | (1) |
|
|
35 | (1) |
|
|
35 | (6) |
|
The Chemistry of Caffeine |
|
|
|
Chapter 3 The Chemistry of Caffeine |
|
|
41 | (12) |
|
|
|
|
In Lieu of an Introduction: Caffeine Trivia |
|
|
|
3.1 Nomenclature and Generic Properties |
|
|
43 | (1) |
|
3.2 Physicochemical Properties |
|
|
44 | (3) |
|
|
47 | (1) |
|
3.4 Technical Substance, Identification and Impurities |
|
|
47 | (1) |
|
|
48 | (1) |
|
3.6 Hazard Classification |
|
|
49 | (4) |
|
|
50 | (1) |
|
|
50 | (1) |
|
|
50 | (3) |
|
Chapter 4 Chemistry and Crystal Structures of Complexes of Caffeine and Tea Catechins |
|
|
53 | (19) |
|
|
|
|
53 | (2) |
|
4.2 Stereochemical Structures of Complexes of Caffeine and Catechins |
|
|
55 | (10) |
|
4.2.1 Complex of Caffeine and CA |
|
|
55 | (4) |
|
4.2.2 Complex of Caffeine and EC |
|
|
59 | (2) |
|
4.2.3 Complex of Caffeine and CA, EC |
|
|
61 | (2) |
|
4.2.4 Complex of Caffeine and Cg |
|
|
63 | (2) |
|
|
65 | (7) |
|
|
66 | (1) |
|
Key Facts of Caffeine and Catechins |
|
|
67 | (1) |
|
Key Facts of Complex of Caffeine and Non-galloylated Catechins |
|
|
67 | (1) |
|
Key Facts of Complex of Caffeine and Galloylated Catechins |
|
|
68 | (1) |
|
Definitions of Words and Terms |
|
|
68 | (1) |
|
|
69 | (1) |
|
|
69 | (3) |
|
Chapter 5 Synthesis of Labeled Caffeine |
|
|
72 | (17) |
|
|
|
72 | (1) |
|
5.2 Strategies for Caffeine Labeling |
|
|
72 | (2) |
|
5.2.1 Synthesis of Labeled Caffeine by Hydrogen Exchange |
|
|
73 | (1) |
|
5.2.2 Synthesis of Labeled Caffeine through Total Synthesis |
|
|
73 | (1) |
|
5.2.3 Synthesis of Labeled Caffeine by Partial Synthesis with a Xanthine Derivative |
|
|
73 | (1) |
|
5.3 Syntheses of Labeled Caffeine |
|
|
74 | (9) |
|
5.3.1 Synthesis of [ 15N2] Caffeine |
|
|
74 | (1) |
|
5.3.2 Syntheses of [ 11C] Caffeine |
|
|
75 | (1) |
|
5.3.3 Syntheses of [ 13C] Caffeine |
|
|
76 | (1) |
|
5.3.4 Syntheses of [ 14C] Caffeine |
|
|
76 | (3) |
|
5.3.5 Syntheses of [ 2H] Caffeine |
|
|
79 | (4) |
|
5.3.6 Syntheses of [ 3H] Caffeine |
|
|
83 | (1) |
|
5.4 Characterization of Labeled Caffeine |
|
|
83 | (6) |
|
5.4.1 Characterization by Nuclear Magnetic Resonance |
|
|
84 | (1) |
|
5.4.2 Characterization by Mass Spectrometry |
|
|
84 | (1) |
|
|
84 | (1) |
|
Key Facts of Labeled Caffeine |
|
|
84 | (1) |
|
Definitions of Words and Terms |
|
|
85 | (1) |
|
|
85 | (1) |
|
|
85 | (4) |
|
Chapter 6 Diffusion of Caffeine in Different Aqueous Media at Physiological Temperature |
|
|
89 | (14) |
|
|
|
|
|
|
89 | (1) |
|
|
90 | (3) |
|
6.2.1 Concepts of Diffusion |
|
|
90 | (2) |
|
6.2.2 Taylor Dispersion Technique |
|
|
92 | (1) |
|
|
93 | (2) |
|
6.3.1 Diffusion of Aqueous Caffeine |
|
|
93 | (1) |
|
6.3.2 Diffusion of Caffeine in the Presence of β-CD |
|
|
93 | (2) |
|
6.3.3 Diffusion of Caffeine in the Presence of HP-β-CD |
|
|
95 | (1) |
|
|
95 | (8) |
|
|
96 | (1) |
|
Key Facts of the Cyclodextrins |
|
|
97 | (1) |
|
Key Facts of the Diffusion |
|
|
97 | (1) |
|
Definitions of Words and Terms |
|
|
97 | (1) |
|
|
98 | (1) |
|
|
98 | (1) |
|
|
98 | (5) |
|
|
|
Chapter 7 Analysis of Caffeine by Liquid Chromatography-Mass Spectrometry |
|
|
103 | (27) |
|
|
|
|
103 | (3) |
|
|
104 | (1) |
|
7.1.2 Pharmacokinetics and Physiological Effects of Caffeine |
|
|
105 | (1) |
|
7.2 Analysis of caffeine and related compounds by LC-MS |
|
|
106 | (15) |
|
|
107 | (5) |
|
|
112 | (2) |
|
7.2.3 Biological Matrices |
|
|
114 | (7) |
|
|
121 | (9) |
|
|
121 | (1) |
|
Key Terms of Caffeine Analysis |
|
|
122 | (1) |
|
Key Facts of Caffeine Analysis |
|
|
122 | (1) |
|
|
123 | (1) |
|
|
124 | (6) |
|
Chapter 8 Simultaneous Determination of Caffeine and Phenolic Compounds in Tea and Coffee |
|
|
130 | (24) |
|
|
|
|
|
|
|
|
130 | (1) |
|
8.2 Determination of Alkaloids and Polyphenols in Tea and Coffee |
|
|
131 | (1) |
|
|
131 | (8) |
|
8.4 Analysis of Alkaloids and Polyphenols in Tea and Coffee Samples |
|
|
139 | (9) |
|
|
148 | (6) |
|
|
148 | (1) |
|
Key Facts of the Chemical Composition of Tea and Coffee |
|
|
149 | (1) |
|
Key Facts of Phenolic Compounds |
|
|
149 | (1) |
|
Key Facts of Determination of Caffeine and Phenolic Compounds in Tea and Coffee |
|
|
150 | (1) |
|
Definition of Words and Terms |
|
|
150 | (1) |
|
|
151 | (1) |
|
|
152 | (2) |
|
Chapter 9 Analysis of Caffeine in Dietary Products by Multiple Injection Capillary Electrophoresis |
|
|
154 | (25) |
|
|
|
154 | (3) |
|
9.2 Methodological Considerations |
|
|
157 | (1) |
|
9.3 Separation of Caffeine and Acetaminophen by Capillary Electrophoresis |
|
|
157 | (3) |
|
9.4 Conversion of the Single Injection Method to Multiple Injection Mode I |
|
|
160 | (2) |
|
|
162 | (6) |
|
9.5.1 Specificity and Selectivity |
|
|
162 | (1) |
|
|
162 | (2) |
|
|
164 | (3) |
|
|
167 | (1) |
|
|
167 | (1) |
|
9.6 System Suitability and Acceptance Criteria |
|
|
168 | (2) |
|
9.7 Determination of Caffeine in Dietary Products |
|
|
170 | (1) |
|
|
171 | (8) |
|
|
173 | (1) |
|
|
174 | (1) |
|
|
174 | (1) |
|
|
175 | (1) |
|
|
175 | (4) |
|
Chapter 10 Determination of Caffeine in Various Coffee Types by Capillary Electrophoresis Through the Anionic Complex with 3,4-Dimethoxycinnamate |
|
|
179 | (14) |
|
|
|
|
179 | (2) |
|
10.2 Capillary Electrophoresis with Capacitively Coupled Contactless Conductivity 00 Detection |
|
|
181 | (3) |
|
10.3 The Formation of π-Complexes of Caffeine and Chlorogenic Acids and Analogues |
|
|
184 | (1) |
|
10.4 The Ionic π-Complex with Cinnamic Acid Derivatives as A Mobile Version of Caffeine and the Resulting Electrophoretic Method |
|
|
184 | (2) |
|
10.5 Validation of the Method |
|
|
186 | (2) |
|
10.6 Decaffeinated Coffee and the Need For a Better Limit of Detection |
|
|
188 | (1) |
|
|
189 | (4) |
|
|
189 | (1) |
|
|
190 | (1) |
|
Definition of Words and Terms |
|
|
190 | (1) |
|
|
191 | (1) |
|
|
191 | (2) |
|
Chapter 11 Analysis of Caffeine and Related Compounds by Automated Flow Methods |
|
|
193 | (20) |
|
|
|
|
193 | (1) |
|
11.2 Automated Flow Injection Techniques |
|
|
194 | (4) |
|
11.2.1 Flow Injection Analysis |
|
|
195 | (1) |
|
11.2.2 Sequential Injection Analysis |
|
|
196 | (1) |
|
11.2.3 Multicommutation-based Flow Injection Techniques |
|
|
197 | (1) |
|
11.3 Determination of Caffeine and Related Compounds by Coupling of SI/FI to Separation Techniques |
|
|
198 | (3) |
|
11.4 Determination of Caffeine and Related Compounds by Flow Optosensors |
|
|
201 | (1) |
|
11.5 Determination of Caffeine and Related Compounds by On-line IR Detection |
|
|
202 | (2) |
|
11.6 Various Flow Injection Methods for the Determination of Caffeine and Related Compounds |
|
|
204 | (9) |
|
11.6.1 Determination of Caffeine by FI Coupled to Amperometric Detection |
|
|
204 | (1) |
|
11.6.2 On-line Extraction of Caffeine from Solid and Slurry Samples |
|
|
204 | (2) |
|
11.6.3 Enzymatic FI Method for the Determination of Theophylline |
|
|
206 | (1) |
|
|
206 | (1) |
|
|
207 | (1) |
|
Key Facts on Flow - Sequential Injection Analysis |
|
|
207 | (1) |
|
Key Facts on Sequential Injection Chromatography |
|
|
207 | (1) |
|
Definitions of Words and Terms |
|
|
208 | (1) |
|
|
209 | (1) |
|
|
210 | (3) |
|
Chapter 12 Analysis of Caffeine by Immunoassay |
|
|
213 | (17) |
|
|
|
12.1 Development of Immunoassays for Caffeine |
|
|
213 | (2) |
|
12.2 Enzyme Immunoassay for Caffeine |
|
|
215 | (10) |
|
|
215 | (1) |
|
12.2.2 A Detailed Experimental Protocol |
|
|
215 | (4) |
|
12.2.3 Quantifying Caffeine in Beverages, Tablets and Shampoo |
|
|
219 | (1) |
|
12.2.4 Immunoassay Cross-Reactivity - Selectivity Towards Caffeine |
|
|
220 | (2) |
|
12.2.5 Comparing the Results with an LC-MS-MS Method |
|
|
222 | (3) |
|
12.3 Final Considerations |
|
|
225 | (5) |
|
|
225 | (1) |
|
Definition of Words and Terms |
|
|
226 | (1) |
|
|
226 | (1) |
|
|
227 | (3) |
|
Chapter 13 Quantification of Self-Reported Caffeine Use |
|
|
230 | (17) |
|
|
|
230 | (1) |
|
13.2 Estimation of Dietary Caffeine Consumption |
|
|
231 | (4) |
|
13.2.1 Self-report Methods |
|
|
231 | (4) |
|
13.3 Standardized Caffeine Content |
|
|
235 | (2) |
|
|
236 | (1) |
|
13.3.2 Controlled-dose Studies |
|
|
237 | (1) |
|
13.4 Self-reported Caffeine Use Validation with Physiological Caffeine Concentrations |
|
|
237 | (2) |
|
|
239 | (8) |
|
|
240 | (1) |
|
Key Facts about Methylxanthines in Coffee, Tea, and Cocoa |
|
|
240 | (1) |
|
Definition of Words and Terms |
|
|
241 | (1) |
|
|
242 | (1) |
|
|
242 | (5) |
|
|
|
Chapter 14 Caffeine and the Brain: An Overview |
|
|
247 | (21) |
|
|
|
|
|
|
|
247 | (1) |
|
14.2 Pharmacokinetic and Pharmacodynamic of Caffeine |
|
|
248 | (1) |
|
14.3 Effects of Caffeine on in vivo Neurotransmitters Release |
|
|
249 | (6) |
|
14.4 Effects of Caffeine on Mechanisms of Synaptic Plasticity |
|
|
255 | (2) |
|
14.5 Caffeine in Neurodegenerative Diseases: Parkinson's and Alzheimer's |
|
|
257 | (11) |
|
|
260 | (1) |
|
|
261 | (1) |
|
Definitions of Words and Terms |
|
|
262 | (1) |
|
|
263 | (1) |
|
|
263 | (5) |
|
Chapter 15 Caffeine and Cognitive Performance |
|
|
268 | (19) |
|
|
Josep Maria Serra-Grabulosa |
|
|
|
268 | (1) |
|
15.2 The Difficulty of Assessing Cognitive Performance |
|
|
269 | (1) |
|
15.3 Effects of Caffeine on Attention and Psychomotor Tasks |
|
|
270 | (2) |
|
15.4 Effects of Caffeine on Memory and Executive Function Tasks |
|
|
272 | (1) |
|
15.5 Effects of Caffeine in Subjective Activation and Affect |
|
|
273 | (4) |
|
15.6 Caffeine Combined With Other Substances |
|
|
277 | (1) |
|
15.7 Caffeine Use in Children and Aged Subjects |
|
|
278 | (1) |
|
15.8 Methodological Difficulties to Solve in the Future |
|
|
279 | (8) |
|
|
281 | (1) |
|
|
282 | (1) |
|
Definitions of Words and Terms |
|
|
282 | (1) |
|
|
283 | (1) |
|
|
283 | (4) |
|
Chapter 16 Neuroprotective Effects of Caffeine in Sleep Deprivation |
|
|
287 | (27) |
|
|
|
|
|
|
287 | (2) |
|
16.2 Sleep and Sleep Cycle |
|
|
289 | (1) |
|
16.2.1 Neurochemistry During Sleep |
|
|
289 | (1) |
|
16.2.2 Sleep Architecture |
|
|
290 | (1) |
|
16.3 Nutrition, Metabolism and Sleep |
|
|
290 | (2) |
|
|
292 | (3) |
|
16.4.1 Sleep Disruption and Neural Function |
|
|
293 | (2) |
|
16.5 Caffeine and Adenosine |
|
|
295 | (4) |
|
16.5.1 Adenosine Pharmacology |
|
|
296 | (1) |
|
16.5.2 Caffeine Pharmacology |
|
|
296 | (1) |
|
16.5.3 Caffeine and Cognitive Function |
|
|
297 | (1) |
|
16.5.4 Caffeine, Sleep Deprivation and LTP Impairment |
|
|
298 | (1) |
|
16.6 Caffeine and Neuroprotection |
|
|
299 | (2) |
|
16.7 Effects of Caffeine on Sleep-Related Neural Signaling Pathways |
|
|
301 | (13) |
|
|
304 | (1) |
|
Definitions of Words and Terms |
|
|
305 | (1) |
|
|
306 | (1) |
|
|
307 | (7) |
|
Chapter 17 Caffeine and Exercise Performance |
|
|
314 | (23) |
|
|
|
|
314 | (1) |
|
17.2 Mechanisms Explaining Ergogenic Effect of Caffeine |
|
|
315 | (2) |
|
17.3 Recommended Dosing, Timing and Form of Caffeine Ingestion |
|
|
317 | (1) |
|
17.4 Tolerance and Withdrawal of Caffeine |
|
|
318 | (1) |
|
17.5 Effects of Caffeine on Exercise Performance |
|
|
318 | (19) |
|
17.5.1 Caffeine and Endurance Exercise |
|
|
318 | (1) |
|
17.5.2 Caffeine and High-Intensity Exercise |
|
|
319 | (1) |
|
17.5.3 Caffeine and Resistance Training |
|
|
319 | (6) |
|
17.5.4 Caffeine and Team Sport Performance |
|
|
325 | (1) |
|
17.5.5 Caffeine and Sprint Performance |
|
|
325 | (1) |
|
|
325 | (1) |
|
Key Facts of Caffeine's Role as an Ergogenic Aid |
|
|
326 | (1) |
|
Definitions of Words and Terms |
|
|
327 | (1) |
|
|
327 | (1) |
|
|
328 | (9) |
|
Chapter 18 The Effects of Caffeine on Ventilation and Pulmonary Function During Exercise |
|
|
337 | (16) |
|
|
|
|
|
337 | (1) |
|
18.2 Effects of Caffeine on Ventilatory Drive |
|
|
338 | (4) |
|
18.2.1 Central and Periphery Chemosensitivity Changes with Caffeine |
|
|
338 | (1) |
|
18.2.2 Caffeine and Ventilation During Exercise |
|
|
339 | (3) |
|
18.3 Potential Ergogenic Effects of Increased Exercise Ventilation |
|
|
342 | (1) |
|
18.4 Potential Negative Consequences of Increased Ventilation During Exercise |
|
|
343 | (2) |
|
18.5 Effects of Caffeine on Pulmonary Function |
|
|
345 | (2) |
|
|
347 | (6) |
|
|
347 | (1) |
|
Key Facts of Ventilatory Control During Exercise |
|
|
348 | (1) |
|
Definition of Words and Terms |
|
|
349 | (1) |
|
|
349 | (1) |
|
|
350 | (3) |
|
Chapter 19 Dietary Caffeine and Young Children: Implications for Health |
|
|
353 | (16) |
|
|
|
|
|
|
19.1 The Prevalence of Caffeine |
|
|
353 | (1) |
|
19.2 Trends in Caffeine Consumption |
|
|
354 | (1) |
|
19.3 The Effects of Caffeine on Children |
|
|
355 | (1) |
|
|
355 | (1) |
|
|
356 | (1) |
|
|
357 | (1) |
|
19.7 Maternal Consumption |
|
|
357 | (1) |
|
|
358 | (1) |
|
|
359 | (10) |
|
|
361 | (1) |
|
|
362 | (1) |
|
Definitions of Words and Terms |
|
|
363 | (2) |
|
|
365 | (1) |
|
|
365 | (4) |
|
Chapter 20 Caffeine and Type 2 Diabetes |
|
|
369 | (13) |
|
|
|
|
369 | (1) |
|
20.2 Type 2 Diabetes: Pathophysiology and Risk Factors |
|
|
369 | (1) |
|
20.3 Coffee Intake and Type 2 Diabetes |
|
|
370 | (1) |
|
20.3.1 Epidemiologic Evidence |
|
|
370 | (1) |
|
20.3.2 Potential Mechanisms |
|
|
370 | (1) |
|
20.4 Caffeine Intake and Type 2 Diabetes Risk |
|
|
371 | (5) |
|
20.4.1 Epidemiologic Evidence |
|
|
371 | (1) |
|
20.4.2 Experimental Evidence |
|
|
372 | (4) |
|
|
376 | (6) |
|
|
376 | (1) |
|
|
377 | (1) |
|
|
377 | (1) |
|
|
377 | (1) |
|
3 Key Facts of Sex Differences in T2D Risk |
|
|
378 | (1) |
|
Definitions of Words and Terms |
|
|
378 | (1) |
|
|
379 | (1) |
|
|
379 | (3) |
|
Chapter 21 Caffeine and Apoptosis |
|
|
382 | (13) |
|
|
|
|
382 | (1) |
|
|
383 | (2) |
|
21.3 Caffeine and ATR-Chk1 |
|
|
385 | (2) |
|
21.4 Caffeine and AKT-COX-2 |
|
|
387 | (1) |
|
21.5 Conclusion and Perspective |
|
|
388 | (7) |
|
|
388 | (1) |
|
|
389 | (1) |
|
|
389 | (1) |
|
|
390 | (1) |
|
|
390 | (1) |
|
|
391 | (1) |
|
|
392 | (1) |
|
Definitions of Words and Terms |
|
|
392 | (3) |
List of Abbreviations |
|
395 | (1) |
Acknowledgement |
|
396 | (1) |
References |
|
396 | (4) |
Subject Index |
|
400 | |